Anticoagulant Use for Atrial Fibrillation Among Persons With Advanced Dementia at the End of Life

JAMA Intern Med. 2021 Aug 1;181(8):1121-1123. doi: 10.1001/jamainternmed.2021.1819.

Abstract

This cross-sectional study evaluates the degree of anticoagulant use among nursing home residents with advanced dementia and atrial fibrillation at the end of life.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Aged, 80 and over
  • Anticoagulants / therapeutic use*
  • Atrial Fibrillation* / drug therapy
  • Atrial Fibrillation* / epidemiology
  • Comorbidity
  • Cross-Sectional Studies
  • Dementia* / diagnosis
  • Dementia* / epidemiology
  • Female
  • Functional Status
  • Homes for the Aged / statistics & numerical data*
  • Humans
  • Life Expectancy
  • Male
  • Medicare / statistics & numerical data
  • Nursing Homes / statistics & numerical data*
  • Risk Assessment
  • Terminal Care* / methods
  • Terminal Care* / standards
  • United States / epidemiology

Substances

  • Anticoagulants